95 related articles for article (PubMed ID: 21290210)
1. Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells.
Kaneno R; Shurin GV; Kaneno FM; Naiditch H; Luo J; Shurin MR
Cell Oncol (Dordr); 2011 Apr; 34(2):97-106. PubMed ID: 21290210
[TBL] [Abstract][Full Text] [Related]
2. Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models.
Žilionytė K; Bagdzevičiūtė U; Mlynska A; Urbštaitė E; Paberalė E; Dobrovolskienė N; Krasko JA; Pašukonienė V
Cancer Immunol Immunother; 2022 Nov; 71(11):2691-2700. PubMed ID: 35364740
[TBL] [Abstract][Full Text] [Related]
3. A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer.
Mayer EL; Tayob N; Ren S; Savoie JJ; Spigel DR; Burris HA; Ryan PD; Harris LN; Winer EP; Burstein HJ
Breast Cancer Res Treat; 2024 Feb; 204(1):123-132. PubMed ID: 38019444
[TBL] [Abstract][Full Text] [Related]
4. The modulation of local and systemic anti-tumor immune response induced by methotrexate nanoconjugate in murine MC38 colon carcinoma and B16 F0 melanoma tumor models.
Szczygieł A; Węgierek-Ciura K; Mierzejewska J; Wróblewska A; Rossowska J; Anger-Góra N; Szermer-Olearnik B; Świtalska M; Goszczyński TM; Pajtasz-Piasecka E
Am J Cancer Res; 2023; 13(10):4623-4643. PubMed ID: 37970366
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer.
Yam C; Mittendorf EA; Garber HR; Sun R; Damodaran S; Murthy RK; Ramirez D; Karuturi M; Layman RM; Ibrahim N; Rauch GM; Adrada BE; Candelaria RP; White JB; Ravenberg E; Clayborn A; Ding QQ; Symmans WF; Prabhakaran S; Thompson AM; Valero V; Tripathy D; Huo L; Moulder SL; Litton JK
Breast Cancer Res Treat; 2023 Jun; 199(3):457-469. PubMed ID: 37061619
[TBL] [Abstract][Full Text] [Related]
6. Combined therapy with methotrexate nanoconjugate and dendritic cells with downregulated IL-10R expression modulates the tumor microenvironment and enhances the systemic anti-tumor immune response in MC38 murine colon carcinoma.
Szczygieł A; Węgierek-Ciura K; Wróblewska A; Mierzejewska J; Rossowska J; Szermer-Olearnik B; Świtalska M; Anger-Góra N; Goszczyński TM; Pajtasz-Piasecka E
Front Immunol; 2023; 14():1155377. PubMed ID: 37033926
[TBL] [Abstract][Full Text] [Related]
7. Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation.
Fabian KP; Kowalczyk JT; Reynolds ST; Hodge JW
Cells; 2022 Nov; 11(23):. PubMed ID: 36497086
[TBL] [Abstract][Full Text] [Related]
8. Metronomic Chemotherapy in Prostate Cancer.
Wysocki PJ; Lubas MT; Wysocka ML
J Clin Med; 2022 May; 11(10):. PubMed ID: 35628979
[TBL] [Abstract][Full Text] [Related]
9. NK Cells in the Tumor Microenvironment as New Potential Players Mediating Chemotherapy Effects in Metastatic Melanoma.
Garofalo C; De Marco C; Cristiani CM
Front Oncol; 2021; 11():754541. PubMed ID: 34712615
[TBL] [Abstract][Full Text] [Related]
10. From Immunogenic Cell Death to Immunogenic Modulation: Select Chemotherapy Regimens Induce a Spectrum of Immune-Enhancing Activities in the Tumor Microenvironment.
Fabian KP; Wolfson B; Hodge JW
Front Oncol; 2021; 11():728018. PubMed ID: 34497771
[TBL] [Abstract][Full Text] [Related]
11. Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment.
Gaggianesi M; Di Franco S; Pantina VD; Porcelli G; D'Accardo C; Verona F; Veschi V; Colarossi L; Faldetta N; Pistone G; Bongiorno MR; Todaro M; Stassi G
Front Oncol; 2021; 11():702642. PubMed ID: 34354950
[TBL] [Abstract][Full Text] [Related]
12. Nab-paclitaxel promotes the cancer-immunity cycle as a potential immunomodulator.
Chen Y; Liu R; Li C; Song Y; Liu G; Huang Q; Yu L; Zhu D; Lu C; Lu A; Li L; Liu Y
Am J Cancer Res; 2021; 11(7):3445-3460. PubMed ID: 34354854
[TBL] [Abstract][Full Text] [Related]
13. The Immunology of Hormone Receptor Positive Breast Cancer.
Goldberg J; Pastorello RG; Vallius T; Davis J; Cui YX; Agudo J; Waks AG; Keenan T; McAllister SS; Tolaney SM; Mittendorf EA; Guerriero JL
Front Immunol; 2021; 12():674192. PubMed ID: 34135901
[TBL] [Abstract][Full Text] [Related]
14. Chemoradiation induces upregulation of immunogenic cell death-related molecules together with increased expression of PD-L1 and galectin-9 in gastric cancer.
Petersen SH; Kua LF; Nakajima S; Yong WP; Kono K
Sci Rep; 2021 Jun; 11(1):12264. PubMed ID: 34112882
[TBL] [Abstract][Full Text] [Related]
15. Repositioning of Antiparasitic Drugs for Tumor Treatment.
Li YQ; Zheng Z; Liu QX; Lu X; Zhou D; Zhang J; Zheng H; Dai JG
Front Oncol; 2021; 11():670804. PubMed ID: 33996598
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory potential of anticancer therapy composed of methotrexate nanoconjugate and dendritic cell‑based vaccines in murine colon carcinoma.
Szczygieł A; Anger-Góra N; Węgierek-Ciura K; Mierzejewska J; Rossowska J; Goszczyński TM; Świtalska M; Pajtasz-Piasecka E
Oncol Rep; 2021 Mar; 45(3):945-962. PubMed ID: 33432365
[TBL] [Abstract][Full Text] [Related]
17. Responses of metastatic primary fallopian tube carcinoma to pembrolizumab and nab-paclitaxel: A case report.
Jiang J; Chen ZP; Zhu HP; Zhang YQ; Qian XL; Zhang M; Ni C; Zuo Y
Medicine (Baltimore); 2020 Jul; 99(28):e21203. PubMed ID: 32664168
[TBL] [Abstract][Full Text] [Related]
18. A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer.
Shi M; Ma T; Xi W; Jiang J; Wu J; Zhou C; Yang C; Zhu Z; Zhang J
Trials; 2020 Mar; 21(1):249. PubMed ID: 32143730
[TBL] [Abstract][Full Text] [Related]
19. Molecular and Kinetic Analyses of Circulating Tumor Cells as Predictive Markers of Treatment Response in Locally Advanced Rectal Cancer Patients.
Troncarelli Flores BC; Souza E Silva V; Ali Abdallah E; Mello CAL; Gobo Silva ML; Gomes Mendes G; Camila Braun A; Aguiar Junior S; Thomé Domingos Chinen L
Cells; 2019 Jun; 8(7):. PubMed ID: 31247977
[TBL] [Abstract][Full Text] [Related]
20. Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience.
Simsek C; Esin E; Yalcin S
J Oncol; 2019; 2019():5483791. PubMed ID: 31015835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
